TITLE

Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion

AUTHOR(S)
Haines, Stuart T.; Dager, William E.; Trujillo, Toby C.
PUB. DATE
May 2010
SOURCE
American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. To illustrate clinical and management issues in the prevention of venous thromboembolism (VTE) in health systems. Summary. Lack of evidence to guide the choice among available anticoagulants and the dosing, timing of initiation, and duration of therapy for VTE prevention in certain clinical situations can present challenges for clinicians. Patient characteristics such as the presence of obesity, epidural catheters, renal impairment, or heparininduced thrombocytopenia complicate the decision-making process. The introduction of new anticoagulants may overcome some of the clinical challenges associated with VTE prophylaxis, but determining whether to add new agents to the formulary and restrict their use may pose management challenges. The safety, effectiveness, ease of use, and cost of new agents compared with older agents already on the formulary are primary considerations. Conclusion. An understanding of the clinical and management issues involved in preventing VTE is needed to improve the use of anticoagulants and reduce the incidence of VTE in health systems.
ACCESSION #
56097240

 

Related Articles

  • Improving anticoagulant use for prevention of venous thromboembolism. Haines, Stuart T. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS2 

    The article discusses various reports published within the issue, including one on the prevention of venous thromboembolism (VTE) as well as the strategies to improve the use of anticoagulant to patients with VTE, one on the use of drug therapies for VTE prophylaxis, and one on the clinical and...

  • Improving anticoagulant use for prevention of venous thromboembolism.  // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS31 

    The article presents a lesson plan for continuing education, which teaches concepts on the use of anticoagulant to prevent venous thromboembolism.

  • Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Palsson, Runolfur; Niles, John L. // Kidney International;May1999, Vol. 55 Issue 5, p1991 

    Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Background. Systemic heparinization is associated with a high rate of bleeding when used to maintain patency of the extracorporeal circuit during continuous renal...

  • Heparin prophylaxis has no benefit in medical patients. Snee, Michael // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/4/2012, Vol. 345 Issue 7868, p29 

    The article discusses about the heparin prophylaxis for venous thromboembolism (VTE). The study found that deep vein thrombosis (DVT) in medical patients cannot to prevented and also found there is no benefit for heparin prophylaxis. The counselling given to the medical patients are highlighted.

  • Delayed-Onset Heparin-Induced Thrombocytopenia. Rice, Lawrence; Attisha, Walid K.; Drexler, Alane; Francis, John L. // Annals of Internal Medicine;2/5/2002, Vol. 136 Issue 3, p210 

    Examines the clinical scenario of heparin-induced thrombocytopenia among patients in the U.S. Significance of early detection of thrombocytopenia for the prevention of arterial or venous thromboemboli; Effects of delayed recognition on patient outcome; Efficacy of anticoagulants in treating...

  • Heparin.  // Reactions Weekly;1/11/2014, Issue 1483, p50 

    The article presents a case report on the adverse reaction of heparin to a 51-year-old man who developed heparin-induced thrombocytopenia and left ventricular (LV) thrombus after receiving the treatment.

  • Heparin.  // Reactions Weekly;Aug2015, Vol. 1563 Issue 1, p115 

    The article presents a case study of an 84-year-old man who developed thrombocytopenia while receiving heparin.

  • Emerging anticoagulants for venous thromboembolism prevention. Trujillo, Toby C. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS17 

    Purpose. To discuss the advantages and disadvantages of currently available anticoagulants, describe the characteristics of the ideal anticoagulant, and compare and contrast the mechanisms of action, pharmacokinetics, administration, efficacy, safety, and potential for drug interactions of...

  • Issues in assessing and reducing the risk for venous thromboembolism. Dager, William E. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS9 

    Purpose. To describe issues and challenges associated with venous thromboembolism (VTE) risk assessment and the use of drug therapies for VTE prophylaxis. Summary. Patients at risk for VTE are aheterogeneous group. Systems for scoring VTE risk have been developed to identify patients who warrant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics